LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
LLY
769.87
+0.76%↑
JNJ
155.03
+1.03%↑
ABBV
189.89
+1.42%↑
NVO
74.74
+3.06%↑
UNH
303.11
+2.59%↑
24h
Current
Min
8.22
Max
9.19
Recommendations | Buy |
---|---|
12 Months Forecast | +8.34% upside |
Next Earnings | 8 sie 2025 |
---|
By Acuity
25%
75%
61 / 380 Ranking in Healthcare
By Trading Central
Confidence
Weak Bearish Evidence
7.245 / 7.64 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
7 mar 2025, 21:54 UTC
Atara Biotherapeutics to Cut Half of Workforce Amid Restructuring
DJ
Read
16 sty 2025, 16:17 UTC
Atara Shares Sink After FDA Stalls Cancer Treatment
DJ
Read
16 sty 2025, 14:31 UTC
FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 10 USD 8.34%
High 17 USD
Low 3 USD
Based on 3 Wall Street analysts offering 12 month price targets forAtara Biotherapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
3 ratings
2
Buy
1
Hold
0
Sell
Based on 3 analysts giving stock ratings to Atara Biotherapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Weak Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
Bearish Evidence
All events are bearish.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
$